Jury orders Olympus to pay hospital $6.6 million but rejects claims scopes are unsafe

Hospital must pay $1 million to deceased patient’s family


A jury ordered Olympus Corp. to pay a Seattle hospital $6.6 million in damages tied to a deadly superbug outbreak, and told the hospital to pay $1 million to a deceased patient’s family, according to an article on the Los Angeles Times website.

But the jurors rejected claims that the company’s flagship medical scope was unsafe as designed.

The case was filed by Theresa Bigler, 61, and her four children in connection with the August 2013 death of Richard Bigler, a pancreatic cancer patient who contracted an infection linked to a contaminated Olympus TJF-Q180V duodenoscope. 

Virginia Mason Medical Center later joined the suit against Olympus, but the jury found it shared some blame in the case.

Read the article.

 



July 31, 2017


Topic Area: Infection Control


Recent Posts

Hospital Evacuation Highlights Importance of Emergency Preparedness

Berger Hospital was evacuated after smoke was discovered in the basement.


Building a Culture of Infection Prevention

Investing in infection prevention can benefit healthcare organizations and patient outcomes.


Ground Broken on Sanford Health Fargo's Peltier Lodge

The 28,400-square-foot facility will feature spaces to support patients and loved ones during treatment and throughout their outpatient care and monitoring.


Arkansas Urology Associates Experiences Data Security Incident

The incident occurred in March.


The Role of Facilities Managers in Healthcare Design

Jiayin Li discusses the way in-house facilities teams can help shape the design of key spaces.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.